KA VIT drops, 5 ml

Instructions for use for KA VIT drops, 5 ml

Field of use

• The preparation contains phytoma adion (vitamin K₁), a means of preventing bleeding.
• Securing area of application for the medicine is the therapy of vitamin K deficiency states and the prevention of vitamin K deficiency states that cannot be remedied in terms of nutrition. This includes:
  • Newborn-vitamin K-prophylaxis immediately after birth, vitamin K prophylaxis in patients with risk factors for the development of a vitamin K deficiency as soon as the quick value drops below the standard limit or the INR value increases over the standard limit,
  • Vitamin K therapy in patients with vitamin K deficiency bleeding, which are usually associated with a quick value below 10% or an INR value of 5 or higher. The vitamin K deficiency bleeding can be caused by a real vitamin K deficiency or by a too high dosage of certain blood-thinning drugs (cumarinity).
• Information on risk factors for a vitamin K deficiency state
  • Risk factors are in newborns and infants:
    • Taking certain drugs (anticonvulsants, tuberculostatics and cumarine attendants) during pregnancy and breastfeeding
    • Early and deficiency birth, complicated birth, later feeding begins, exclusive breast nutrition and inadequate feeding.
  • Risk factors are in the infant, older child and adults:
    • disturbed intake of certain substances from the intestine (malabsorption syndromes), nutrition through direct infusion in the blood circulation (parenteral diet), traffic jam of bile within the biliary gang (bile duct, alpha-1 antitrypsin deficiency, cytomegalie virus infection, closure arctice)
    • Diseases of the pancreas, reduced amount of certain protein fabrics in the blood (A-ß-lipoproteinemia), treatment with antibiotics (especially cephalosporins), sulfonamides or salicylates.
• Notes on deficiency symptoms
  • Vitamin K deficiency symptoms can be caused
    • by a real lack of vitamin K (e.g. due to nutritional or by disturbed recording in the intestine)
    • when using blood clotting drugs (cumarinians such as phenprocoumon or warfarin) or by various inhibitors of the vitamin_KEpoxidDreduktasis, bruises (hematoma) are broken (hematomas), through bleeding black stool , Melaena), red colored urine (hematuria) and severe headache, dizziness or symptoms of brain bleeding.

Active ingredients / ingredients / ingredients

20 mg phytomenadion
Dinatrium Edetat Hedge substance (+)
Polysorbate 80 HILDVERSTOFT (+)
Water, cleaned auxiliary material (+)
Sorbic acid auxiliary material (+)
23 mg total sodium ion hedge material (+)
Total sodium ion helper (+)

Contradictions

• The medicine must not be taken,
  • if you are allergic to phytoma adion (vitamin K₁) or one of the other components of this drug.

dosage

• Always take this medicine exactly as described or exactly after the agreement made with your doctor or pharmacist. Ask your doctor or pharmacist if you are not sure.
• Application for newborns
  • How vitamin K₁ is used in newborns depends on the purpose for which it is given and whether your baby was born too early.
• Dosage to prevent a vitamin K deficiency
  • Healthy newborns who were born to or shortly before the calculated date of birth are preserved:
    • a first dose of 2 drops (corresponding to 2 mg vitamin K₁) at or shortly after birth.
    • a second dose of 2 drops 3 to 10 days nach of the birth
    • a third dose of 2 drops 4 to 5 weeks after birth
  • In infants that are fed exclusively with the bottle (with infant food), the third dose can be omitted.
• Premature babies or mature born with a particularly high bleeding risk
  • These children should receive vitamin K₁ as a syringe (injection). The medicine is not suitable for this; Your doctor will use a different medicine for this.
• Dosage for treatment for vitamin K deficiency bleeding
  • In patients with vitamin K deficiency bleeding, the medicine should be dosed according to the desired effect:
    • With lighter bleeding, a dose of 1 - 5 mg phytoma adion (corresponding 1 - 5 drops) is generally sufficient for the age of the patient.
    • In patients with vitamin K deficiency bleeding as a result of an overdose of blood clotting medicines (cumarinians such as phenprocoumon or warfarin), which have lighter bleeding, it is usually sufficient to stop stopping anticoagulans.
    • In the event of moderate bleeding, the administration of 5 - 10 mg phytomenadion (corresponding to 5 - 10 drops) is recommended.

• Duration of the application
  • If you take long -term, you should ask the doctor.

• If you have taken a larger amount than you should
  • No toxic phenomena have so far become known after overdose.

• If you have forgotten the intake
  • Do not take the double dose if you have forgotten the prior intake.

• If you cancel the intake
  • Please speak to your doctor or pharmacist if you stop taking it. Under certain circumstances, the tendency to bleed can reappear.

• If you have any further questions about taking this medicine, please contact your doctor or pharmacist.

Taking

• The drops are only suitable for taking it.
• The intake should take place together with some liquid.
• By holding the bottle vertically downwards, you can dose the emulsion drops drop by drop

Patient information

• Warnings and Precautions
  • Please speak to your doctor or pharmacist before taking the medicine,
    • if you have to take medicinal products regularly against blood clotting disorders (cumarinoism), you should only take the medicine with more detailed compliance with the dosage required by the doctor. In this case, the risk of vascular closure (thrombosis) can result from the cancellation of the cumarin effect because the coagulation -promoting factors are activated faster by vitamin K₁ than the coagulation.

• Wateriness and ability to operate machines
  • Special precautions are not required.

Pregnancy

• If you are pregnant or breastfeed, or if you suspect that you are pregnant or intend to become pregnant, ask your doctor or pharmacist for advice before taking this drug.
• Previous experiences in taking vitamin K₁ In pregnant and breastfeeding, therapeutic dosage have shown no harmful effect.

Hints